Literature DB >> 18206534

The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway.

Youfeng Yang1, Hesed M Padilla-Nash, Manish A Vira, Mones S Abu-Asab, Daniel Val, Robert Worrell, Maria Tsokos, Maria J Merino, Christian P Pavlovich, Thomas Ried, W Marston Linehan, Cathy D Vocke.   

Abstract

The establishment, characterization, and tumorigenicity of a new epithelial cell line (UOK 257) derived from human renal carcinoma of an individual with Birt-Hogg-Dubé (BHD) syndrome are reported. Unlike other established renal tumor cell lines from sporadic renal cell carcinoma, this is the first established renal tumor cell line of BHD, an inheritable neoplastic syndrome. The isolated tumor cells display loss of contact inhibition in vitro, and produce subcutaneous tumors in mouse xenografts. Histopathologic, ultrastructural, and cytogenetic characterizations of the established tumor cells are reported. Cytogenetic analysis using spectral karyotyping on UOK 257 cells revealed 17p loss and a near-triploid and aneuploid karyotype with multiple fluorescence in situ hybridization analysis using a locus-specific gene probe for MYC. The result demonstrates that the established tumor cells consist of two cell populations, one containing four and one containing five copies of the MYC oncogene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206534      PMCID: PMC2440670          DOI: 10.1016/j.cancergencyto.2007.10.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  15 in total

1.  Spectral karyotyping analysis of human and mouse chromosomes.

Authors:  Hesed M Padilla-Nash; Linda Barenboim-Stapleton; Michael J Difilippantonio; Thomas Ried
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Multicolor spectral karyotyping of human chromosomes.

Authors:  E Schröck; S du Manoir; T Veldman; B Schoell; J Wienberg; M A Ferguson-Smith; Y Ning; D H Ledbetter; I Bar-Am; D Soenksen; Y Garini; T Ried
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

3.  Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.

Authors:  Masaya Baba; Seung-Beom Hong; Nirmala Sharma; Michelle B Warren; Michael L Nickerson; Akihiro Iwamatsu; Dominic Esposito; William K Gillette; Ralph F Hopkins; James L Hartley; Mutsuo Furihata; Shinya Oishi; Wei Zhen; Terrence R Burke; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-06       Impact factor: 11.205

Review 4.  Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.

Authors:  Brian P Adley; Norm D Smith; Ritu Nayar; Ximing J Yang
Journal:  Arch Pathol Lab Med       Date:  2006-12       Impact factor: 5.534

5.  High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.

Authors:  Cathy D Vocke; Youfeng Yang; Christian P Pavlovich; Laura S Schmidt; Michael L Nickerson; Carlos A Torres-Cabala; Maria J Merino; McClellan M Walther; Berton Zbar; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

6.  Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.

Authors:  S K Khoo; M Bradley; F K Wong; M A Hedblad; M Nordenskjöld; B T Teh
Journal:  Oncogene       Date:  2001-08-23       Impact factor: 9.867

7.  Renal oncocytosis: a morphologic study of fourteen cases.

Authors:  S K Tickoo; V E Reuter; M B Amin; J R Srigley; J I Epstein; K W Min; M A Rubin; J Y Ro
Journal:  Am J Surg Pathol       Date:  1999-09       Impact factor: 6.394

8.  Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors.

Authors:  Guorong Li; Michèle Cottier; Odile Sabido; Anne Gentil-Perret; Claude Lambert; Christian Genin; Jacques Tostain
Journal:  Cell Oncol       Date:  2005       Impact factor: 6.730

9.  The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.

Authors:  A J Garvin; G G Re; B I Tarnowski; D J Hazen-Martin; D A Sens
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

10.  Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma.

Authors:  S Gad; S H Lefèvre; S K Khoo; S Giraud; A Vieillefond; V Vasiliu; S Ferlicot; V Molinié; Y Denoux; N Thiounn; Y Chrétien; A Méjean; M Zerbib; G Benoît; J M Hervé; G Allègre; B Bressac-de Paillerets; B T Teh; S Richard
Journal:  Br J Cancer       Date:  2006-11-28       Impact factor: 7.640

View more
  33 in total

1.  Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells.

Authors:  Girma M Woldemichael; Thomas J Turbyville; W Marston Linehan; James B McMahon
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

Review 2.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

3.  Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).

Authors:  Youfeng Yang; Cathy D Vocke; Christopher J Ricketts; Darmood Wei; Hesed M Padilla-Nash; Martin Lang; Carole Sourbier; J Keith Killian; Shawna L Boyle; Robert Worrell; Paul S Meltzer; Thomas Ried; Maria J Merino; Adam R Metwalli; W Marston Linehan
Journal:  Genes Chromosomes Cancer       Date:  2017-07-24       Impact factor: 5.006

4.  Ciliary localization of folliculin mediated via a kinesin-2-binding motif is required for its functions in mTOR regulation and tumor suppression.

Authors:  Yunlong Zhang; Ying Liu; Yu Dai; Yazhe Ren; Guangsen Bao; Bo Ai; Yu Jiang
Journal:  FEBS Lett       Date:  2020-11-20       Impact factor: 4.124

5.  Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.

Authors:  Lene Clausen; Amelie Stein; Martin Grønbæk-Thygesen; Lasse Nygaard; Cecilie L Søltoft; Sofie V Nielsen; Michael Lisby; Tommer Ravid; Kresten Lindorff-Larsen; Rasmus Hartmann-Petersen
Journal:  PLoS Genet       Date:  2020-11-02       Impact factor: 5.917

6.  The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Authors:  T R Hartman; E Nicolas; A Klein-Szanto; T Al-Saleem; T P Cash; M C Simon; E P Henske
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

7.  UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.

Authors:  Youfeng Yang; Vladimir A Valera; Hesed M Padilla-Nash; Carole Sourbier; Cathy D Vocke; Manish A Vira; Mones S Abu-Asab; Gennady Bratslavsky; Maria Tsokos; Maria J Merino; Peter A Pinto; Ramaprasad Srinivasan; Thomas Ried; Len Neckers; W Marston Linehan
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

8.  The Birt-Hogg-Dubé tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis.

Authors:  Kriti Gaur; Jinghong Li; Dakun Wang; Pranabananda Dutta; Shian-Jang Yan; Amy Tsurumi; Hartmut Land; Guan Wu; Willis X Li
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

9.  Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality.

Authors:  Carole Sourbier; Bradley T Scroggins; Ranjala Ratnayake; Thomas L Prince; Sunmin Lee; Min-Jung Lee; Peter Literati Nagy; Young H Lee; Jane B Trepel; John A Beutler; W Marston Linehan; Len Neckers
Journal:  Cancer Cell       Date:  2013-01-23       Impact factor: 31.743

10.  Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.

Authors:  Laura S Schmidt
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.